Iovance Biotherapeutics releases corporate overview

Iovance Biotherapeutics Inc. filed a regulatory exhibit outlining a corporate overview and forward-looking statements, which includes risk factors and details regarding commercial product development. Sentiment remains neutral as this is a standard informational filing.